FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically to cardiology and concerns medical treatment of chronic cardiac insufficiency. For this purpose bone marrow cells (BMC) are sampled, BMC mononuclear fraction is released in vitro, this fraction is cultivated in gas environment during 7-10 days followed by intramyocardial or intracoronary introduction to patient. At that immunocorrecting agents are introduced as during cell cultivation so after transplantation. Method provides improved regenerative ability of BMC owing to optimal period of cultivation and correction of immune system of patients with chronic cardiac insufficiency.
EFFECT: improved regenerative ability of bone marrow cells.
2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING CHRONIC DISEASES (VARIANTS), METHOD FOR OBTAINING A BIOTRANSPLANT (VARIANTS), A BIOTRANSPLANT (VARIANTS) | 2006 |
|
RU2322248C2 |
BIOTRANSPLANT AND METHOD FOR TREATING CHRONIC CARDIAC FAILURE (VARIANTS) | 2005 |
|
RU2299073C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING ISCHEMIC CARDIAC DISEASE | 2004 |
|
RU2268061C1 |
METHOD OF IMMUNODEPENDANT COMPLICATIONS PREVENTION FOR CARDIOSURGERY PATIENTS IN POSTOPERATIVE PERIOD | 2006 |
|
RU2326679C1 |
METHOD OF TREATING CARDIOVASCULAR DISEASE | 2023 |
|
RU2822010C1 |
METHOD FOR TREATING THE CASES OF NON-OPERABLE CARDIOLOGIC PATIENTS | 2004 |
|
RU2250772C1 |
BIOTRANSPLANT, METHOD FOR ITS OBTAINING (VARIANTS) AND METHOD FOR TREATING DILATION CARDIOMYOPATHY | 2004 |
|
RU2268062C1 |
BIOTRANSPLANT CONTAINING NUCLEUS-CONTAINING BONE MARROW CELLS INCLUDING PREDIFFERENTIATED IN ENDOTHELIAL AND CARDIOMYOCYTIC DIRECTION, METHOD FOR PRODUCING IT AND METHOD FOR TREATING CARDIAC INSUFFICIENCY CASES | 2006 |
|
RU2314816C2 |
METHOD FOR TREATING PATIENTS WITH THE DEFECTS OF CARDIAC VALVES | 2006 |
|
RU2311140C1 |
METHOD OF SURGICAL TREATMENT OF HEART DISEASES OF ISCHEMIC GENESIS | 2005 |
|
RU2361529C2 |
Authors
Dates
2008-06-10—Published
2006-10-17—Filed